Actavis News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.05.18	Stroock Adds Experienced Real Estate Capital Markets Lawyer Evan Hudson as Partner in New York (PR Newswire)
22.01.18	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Bioverativ Inc. (PR Newswire)
30.11.17	Verizon announces extension of early participation date and early results of its tender offers / consent solicitations for 31 series of Verizon and certain of its subsidiaries' notes (PR Newswire)
03.05.17	Online Job Ads Declined 26,100 in April (PR Newswire)
28.05.15	FDA Approves IBS-D Drugs, GBIM Plunges On Hepatitis B Drug Data, RTRX On A High (RTTNews)
27.04.15	ACT Gets Its Act Right, AKRX Shrivels, CUPID2 Misses Targets, GWPH On A High (RTTNews)
24.04.15	Actavis Plc: DALVANCE Phase 3 Trial Achieves Primary Endpoint - Quick Facts (RTTNews)
31.03.15	Amneal Signs Deal To Buy Generic Business Of Actavis Australia;Terms Undisclosed (RTTNews)
17.03.15	Actavis Appoints Two Former Members Of Allergan Board To Its Board - Quick Facts (RTTNews)
04.03.15	Actavis Places Second-Largest Bond Offering Ever (RTTNews)
27.02.15	Actavis: FDA OKs LILETTA To Prevent Pregnancy For Up To 3 Years - Quick Facts (RTTNews)
18.02.15	Actavis Plans To Adopt "Allergan" Corporate Name - Quick Facts (RTTNews)
18.02.15	Actavis Q4 Profit Tops Estimates - Quick Facts (RTTNews)
18.02.15	Eagle Soars, VBLT Crushed Over Drug Failure, Study Fails To Soothe CLTX (RTTNews)
05.02.15	AstraZeneca Q4 Adj. Profit Misses View, To Buy Actavis' Respiratory Drug Unit (RTTNews)
05.02.15	DPLO To Dispense Breast Cancer Drug, New Use For Old Drugs Sought, CANF On Watch (RTTNews)
05.02.15	AstraZeneca To Buy Actavis' U.S. Respiratory Portfolio - Quick Facts (RTTNews)
26.01.15	Actavis To Acquire Auden Mckenzie For GBP306 Mln Plus Royalty - Quick Facts (RTTNews)
12.01.15	Actavis Expects Q4 Adj. EPS To Exceed Wall Street Consensus Estimates (RTTNews)
06.01.15	Actavis Announces FDA Receipt Of NDA Resubmission For Cariprazine - Quick Facts (RTTNews)
24.12.14	Actavis Confirms Receipt Of CRL For Nebivolol/Valsartan FDC For Hypertension (RTTNews)
24.12.14	Actavis, Adamas Pharma Win FDA Approval For Alzheimer's Drug Namzaric (RTTNews)
20.12.14	Actavis Considers Offer For Almirall : Report (RTTNews)
16.12.14	Actavis CEO Brent Saunders To Continue At Helm Upon Acquisition Of Allergan (RTTNews)
10.12.14	Actavis Unveils Generic Version Of Celebrex - Quick Facts (RTTNews)
17.11.14	Reports: Actavis Nears Deal To Acquire Allergan (RTTNews)
13.11.14	FDA Accepts Actavis' Filing Of SNDA For Saphris - Quick Facts (RTTNews)
16.10.14	Actavis Confirms Generic Quillivant XR Patent Litigation (RTTNews)
03.10.14	Salix Pharma Ends Cosmo Deal; Stock Up On Reports Of Talks For Sale To Actavis (RTTNews)
03.10.14	Salix Pharma And Cosmo Pharma Agree To Terminate Merger Agreement - Quick Facts (RTTNews)
23.09.14	Reports: Allergan In Advanced Talks To Acquire Salix Pharmaceuticals (RTTNews)
19.08.14	Actavis Reports Positive Results From Ceftazidime-Avibacta Phase III Studies (RTTNews)
02.07.14	Actavis Closes Acquisition Of Furiex Pharma - Quick Facts (RTTNews)
01.07.14	Actavis Closes Acquisition Of Forest Labs - Quick Facts (RTTNews)
01.07.14	FTC Puts Conditions On Actavis Deal To Buy Forest Laboratories (RTTNews)
30.06.14	Actavis Confirms Generic Zubsolv Patent Challenge - Quick Facts (RTTNews)
19.06.14	Actavis Confirms Court Ruling In Generic Exelon Patch Patent Suit (RTTNews)
14.05.14	Actavis Plans New Leadership Team Post Forest Labs. Acquisition - Quick Facts (RTTNews)
12.05.14	Actavis Settles Patent Litigation Related To Its Generic Version Of Acanya (RTTNews)
01.04.14	Actavis Buys Silom Medical For $100 Mln In Cash - Quick Facts (RTTNews)
24.12.13	FDA Seeks More Details On Actavis' NDA For Progestin-only Contraceptive Patch (RTTNews)
14.11.13	Actavis Confirms Generic Axiron Patent Challenge (RTTNews)
29.10.13	Actavis Q3 Adj. Earnings Matches View, Lifts Full-year Outlook - Quick Facts (RTTNews)
14.10.13	Clinical Trial Results, Conference Calls, and Acquisitions - Research Report on Pfizer, UnitedHealth, Actavis, Bristol-Myers Squibb, and Quest Diagnostics (PR Newswire)
02.10.13	Actavis plc Names Board of Directors (PR Newswire)
01.10.13	Today's Technical View: Avanir Pharmaceuticals Inc., Warner Chilcott PLC, Actavis Inc., and Dynavax Technologies Corp. (PR Newswire)
01.10.13	Actavis Completes Warner Chilcott Acquisition (PR Newswire)
27.09.13	Actavis and Warner Chilcott Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Warner Chilcott (PR Newswire)
26.09.13	Regulatory Approvals, Positive Stock Price Movements, Optimistic Clinical Data, and New Launches and Contracts - Research Report on Johnson & Johnson, Celldex, Isis, Actavis, and Centene (PR Newswire)
25.09.13	Actavis, Inc. to Host Third Quarter 2013 Earnings Conference Call and Webcast (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	71.72	2.37 %	K V
UBS Group	28.03	1.30 %	K V
Part Grp Hldg	1’267.00	1.04 %	K V
Swiss Re	129.55	0.66 %	K V
Lonza Grp	520.20	0.62 %	K V
Roche Hldg G	252.50	0.00 %	K V
Nestle	76.14	-0.29 %	K V
CieFinRichemont	121.25	-0.53 %	K V
Sonova Hldg	302.00	-0.66 %	K V
Givaudan	3’851.00	-0.75 %	K V

Nachrichten zu Actavis Inc

Aktien Top/Flop

Actavis Peer Group Nachrichten

Meistgelesene Nachrichten